Losartan

Cozaar | Lortaan

FDA ApprovedCardiovascular AgentsARBs
FDA: 1995Half-life: 2 hours (losartan); 6-9 hours (active metabolite)Pregnancy: Category D

Overview

Selectively blocks binding of angiotensin II to AT1 receptors, producing vasodilation, reduced aldosterone secretion, and decreased blood pressure.

Indications

  • Hypertension
  • Diabetic nephropathy (type 2 diabetes)
  • Stroke risk reduction in patients with hypertension and left ventricular hypertrophy
  • Heart failure (when ACE inhibitors not tolerated)

Contraindications

  • Pregnancy
  • Concurrent use with aliskiren in patients with diabetes
  • History of angioedema with ARBs

Classification

Mechanism of Action

Selectively blocks binding of angiotensin II to AT1 receptors, producing vasodilation, reduced aldosterone secretion, and decreased blood pressure.

Pharmacodynamics

ARB (angiotensin II receptor blocker). Does not inhibit ACE or accumulate bradykinin (fewer cough side effects than ACE inhibitors).

Pharmacokinetics

Absorption
Well absorbed orally. Undergoes significant first-pass metabolism.
Distribution
Does not cross blood-brain barrier well.
Metabolism
Hepatic via CYP2C9 and CYP3A4 to active metabolite (EXP-3174) which is 10-40x more potent.
Excretion
Renal (35%) and fecal (60%).
Half-life
2 hours (losartan); 6-9 hours (active metabolite)
Bioavailability
25-35%
Protein Binding
98.7%

Dosage

Typical dosage: 25-100mg once or twice daily

Available Forms

  • Tablet

Side Effects

Common

  • Dizziness
  • Upper respiratory infection
  • Nasal congestion
  • Back pain

Serious

  • Hyperkalemia
  • Acute renal failure
  • Angioedema (rare)

Rare

  • Hepatitis
  • Rhabdomyolysis
  • Vasculitis

Drug Interactions

moderate

Risk of hyperkalemia. Monitor potassium levels, especially with renal impairment.

moderate

ARBs may increase lithium levels. Monitor lithium concentration closely.

Warnings

⚠️BLACK BOX WARNING

Drugs that act on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue as soon as pregnancy is detected.

Pregnancy

Category D

Toxicity

LD50 >1000 mg/kg (oral, rat)

Overdose

Symptoms: hypotension, tachycardia, bradycardia. Treatment: supportive, IV fluids. Not removed by hemodialysis.

References

Looking for patient-friendly information? Visit RemedyDoor for easy-to-read guides about this medication.